Indefinite Delivery Contract HHSN268201300009C
Award Date 2/25/13
Last Date to Order 6/4/13
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies, has been awarded a single-award Indefinite Delivery Contract (IDC) by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH). The IDC has a ceiling value of $92,416,478 and a period of performance through March 2, 2026. Under this IDC and associated delivery orders, Illumina will provide a range of its advanced sequencing instruments,...
- The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health, awarded a single-award Indefinite Delivery Contract (IDC) to Illumina, Inc. worth up to $767,216.60 for the procurement of TAS::75 0888::TAS SY-401-1001 HISEQ 2000 products and services. The period of performance is from May 27, 2011 to May 29, 2012. Illumina, a for-profit manufacturer of genetic sequencing and genomic analysis instruments and reagents, has previously received prime...
- This Indefinite Delivery Contract (IDC) was awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. The $992,022 IDC provides for the delivery of NextSeq 500 High Output Reagent Kits to support the FDA's nucleic acid sequencing needs, with no set-aside provisions. Three delivery orders have been issued against the IDC, valued at $38,896, $193,380, and $237,188 respectively, for the purchase of...
- This federal Indefinite Delivery Contract (IDC) was awarded by the National Oceanic and Atmospheric Administration (NOAA), a civilian agency, to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $479,095.62 IDC, which has a period of performance through April 2025, enables NOAA to procure a range of Illumina sequencing instruments, reagents, consumables, and support services to support the agency's scientific research and diagnostic...
- The National Human Genome Research Institute awarded a single-award indefinite-delivery contract to Illumina, Inc. on May 22, 2026, with a $90 million ceiling and an ultimate completion date of May 21, 2031. The contract procures Illumina reagents and consumables under Executive Order 14398. Place of performance includes San Diego, California (the prime's manufacturing and administrative location) and Bethesda, Maryland (the funding agency's site). The IDIQ covers Illumina's comprehensive...
- The Department of the Navy Bureau of Medicine and Surgery awarded an Indefinite Delivery Contract (IDC) worth up to $3,332,295.75 to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents. Under this single-award IDC, Illumina will provide nucleic acid sequencing reagents and positive controls for MiSeq, iSeq, NextSeq, and NovaSeq6000 sequencing instruments used by the Naval Medical Research Center's Biological Defense Research Directorate (NMRC-BDRD) to characterize...
- The Department of Health and Human Services Food and Drug Administration (FDA) awarded an Indefinite Delivery Contract (IDC) to Illumina, Inc., a manufacturer of genomic sequencing instruments and reagents, for the provision of Reagent (Chemistry) Kits. The single-award IDC has a ceiling value of $19,500,000 and an ultimate completion date of September 14, 2022. Under this contract, the FDA has issued a series of firm fixed-price delivery orders to Illumina for the supply of various chemistry...
- The Central Program Planning Coordination and Support office (a civilian federal agency) awarded a single-award indefinite-delivery contract to Illumina, Inc. on May 22, 2020, with a $35 million ceiling and an ultimate completion date of May 25, 2025, to supply laboratory equipment, consumables, and services including genetic sequencing instruments, reagents, and maintenance support. Place of performance encompasses multiple USDA regional and functional divisions and subordinate facilities...
- The National Institute of Standards and Technology (NIST), a civilian federal agency, awarded a Blanket Purchase Agreement (BPA) contract to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The BPA allows NIST to quickly procure Illumina's proprietary sequencing systems, reagents, and consumables to support their genomic research and analysis needs. Under this BPA, NIST has issued multiple firm fixed price call orders to Illumina, with a total contract...
- The Food and Drug Administration awarded a single-award Indefinite Delivery Contract to Illumina, Inc. on November 28, 2022, with a ceiling of $25 million for Illumina reagent chemistry kits, with an ultimate completion date of January 29, 2028. Place of performance encompasses multiple FDA facilities across the United States, including Silver Spring, Maryland; Laurel, Maryland; Berwyn Heights, Maryland; Irvine, California; Alameda, California; Bothell, Washington; Jamaica, New York; Everett,...